Galbraith Kenneth
- SEC CIK
- 0001567045
In the past year, 3 open-market sale filings worth $3.34M and no purchases.
Current role at each company
- ZYME Zymeworks Inc.Chair & CEOas of Jan 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.34M
- 3 filings
- Net
- −$3.34M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Galbraith Kenneth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 (view filing) | Jan 12 | Same day | Galbraith KennethChair & CEO | SSale | −30.4K | $22.67 | −$689.7K | −11.8%226.8K after | |
| Jan 5, 2026 (view filing) | Jan 5 | Same day | Galbraith KennethChair & CEO | SSale | −54.3K | $25.10 | −$1.36M | −21.9%193.3K after | 2 lots |
| Dec 22, 2025 (view filing) | Dec 22 | Same day | Galbraith KennethChair & CEO | SSale | −47.5K | $27.02 | −$1.28M | −26.3%133.3K after | |
| Jan 6, 2025 (view filing) | Jan 6 | Same day | Galbraith KennethChair & CEO | SSale | −57.3K | $14.92 | −$854.8K | −41.5%80.8K after | 2 lots |
| Jan 8, 2024 (view filing) | Jan 5-8 | 3 days | Galbraith KennethChair & CEO | SSale | −23.9K | $10.79 | −$257.8K | −50.1%23.8K after | 2 lots |